RemeGen Co

RemeGen Co Gross Margin

The Gross Margin of RemeGen Co (688331.SS) as of Oct 26, 2026 is 100.00 %. In the previous year, Gross Margin was 79.81 % — a change of 25.31% (higher).

Gross Margin

100.00 %

YoY

25.31%

Last updated:

Gross Margin of RemeGen Co is 2025 100.00 % . Gross Margin of RemeGen Co was 2024 79.81 % . It decreases by 25.31% higher compared to the previous year.

For RemeGen Co, the gross margin of 100.0% is up versus 95.3% a few years ago.

The RemeGen Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
21.10 CNY
Jan 1, 2019
-1,584.43 CNY
Jan 1, 2020
15,984.48 CNY
Jan 1, 2021
95.28 CNY
Jan 1, 2022
64.77 CNY
Jan 1, 2023
76.24 CNY
Jan 1, 2024
79.81 CNY
Jan 1, 2025
100.00 CNY
The RemeGen Co Gross Margin history
YEARGross MarginYoY
100.00 %+25.31%
79.81 %+4.67%
76.24 %+17.72%
64.77 %-32.03%
95.28 %-99.40%
15,984.48 %-1,108.85%
-1,584.43 %-7,608.30%
21.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Gross Margin of RemeGen Co is 100.00 % in 2025.

Gross Margin of RemeGen Co changed from 79.81 % to 100.00 %, representing a 25.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's RemeGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — RemeGen Co

All Key Metrics — RemeGen Co